Join
Live feed
·
PRReleasevia Quantisnow
Novavax Inc. logo

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies

ByQuantisnow·Wall Street's wire, on your screen.
NVAX· Novavax Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NVAX (Novavax Inc.) and more on Quantisnow.